HBIO
HBIO
NASDAQ · Life Sciences Tools & Services

Harvard Bioscience Inc

$9.52
+0.31 (+3.31%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +275.5% upside
Low Target $24.20
Average Target $35.75
High Target $46.73
Current Price $9.52
Current
$9.52
Target
$35.75
$24.20 $35.75 avg $46.73
Scenario Analysis
Bear Case
$24.20
154.2%
Low target
Base Case
$35.75
+275.5%
Avg target
Bull Case
$46.73
+390.9%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$9.10
4.6% from high
52-Week Low
$4.00
+138.0% from low
Target vs 52W High
$35.75
+292.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 79% $369.21 -46.8%
DHR
Danaher Corp
Strong Buy 31 84% $158.11 -31.3%
A
Agilent Technologies Inc
Buy 30 73% $64.69 -62.6%
IQV
Iqvia Holdings Inc
Strong Buy 26 92% $82.96 -69.4%
WAT
Waters Corp
Strong Buy 28 75% $189.60 -59.0%
MTD
Mettler-Toledo International
Hold 19 47% $170.43 -90.2%
ILMN
Illumina Inc
Hold 28 54% $169.36 -19.2%
WST
West Pharmaceutical Services
Strong Buy 21 95% $136.24 -66.9%